NuScale stock is up about 37% in the brand-new year, helped by the Trump administration's recent award of $2.7 billion to ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

Handle millions of rows by loading queries into Power Pivot, building relationships, and creating measures for fast variance ...

If you are wondering whether Occidental Petroleum is attractively priced or not, this article walks through the key numbers ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Peter Krull, director of Earth Equity Advisors, discusses why he's bullish on renewable energy and shares his top clean ...